Initiation of Buprenorphine in Outpatient Settings – CEU’s

Sponsor: Grayken Center for Addiction TTA; a program of Boston Medical Center

This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.

Description

This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.

Intended audience

Medical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine.

Speakers

Andrea Jodat, DNP, FNP-BC, CARN-AP (she/her)

Andrea is a clinical nurse educator for Boston Medical Center’s Grayken Center for Addiction Training and Technical Assistance, where she contributes to the development and delivery of continuing education programs, peer-reviewed publications, evidence-based clinical guidelines, and other resources for providers supporting patients with substance use disorders. She is also a family nurse practitioner at Boston Medical Center, an assistant professor of medicine at the Boston University Chobanian & Avedisian School of Medicine, and conducts research in the use of telehealth and coordinated care for persons with opioid use disorder and depression. Andrea is an active member of the Boston University Medical Group Advanced Practice Provider Council and the Massachusetts Coalition of Nurse Practitioners. Andrea has worked with vulnerable populations for over 10 years including managing substance use disorders and overall healthcare for persons experiencing homelessness with the Boston Health Care for the Homeless Program. She is a term lecturer and preceptor for nurse practitioner students at the Massachusetts General Hospital Institute of Health Professions (IHP) and received her Doctor in Nursing Practice (DNP) degree from the IHP in 2018. She also holds certification as a Certified Addiction Registered Nurse – Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board (ANCB).

Nancy Regan-Brooks, MSN, FNP, CNM, CARN-AP (she/her)

Nancy is a clinical nurse educator for Boston Medical Center’s Grayken Center for Addiction Training and Technical Assistance, where she contributes to the development and delivery of continuing education programs, peer-reviewed publications, evidence-based clinical guidelines, and other resources for providers supporting patients with substance use disorders. Nancy is also a nurse practitioner, board certified in both family medicine and midwifery with over a decade of experience working in addiction treatment. Prior to joining the Grayken TTA team, Nancy held a position as director of the substance use disorder program at the Community Health Center of Cape Cod, where she maintains clinical practice. Nancy began her career in a community health center in South Boston managing a wide range of pediatric, prenatal, and adult patients. She later transitioned to addiction medicine at High Point Treatment Center in Jamaica Plain where she worked in an acute treatment setting of medically supervised detoxification and treated acute and chronic medical issues on a Crisis Stabilization Services Unit. Nancy also participated in the HEALing Communities Study — a multi-state study funded by the National Institute on Drug Abuse aimed at reducing overdose deaths — as a lead community partner, facilitating treatment on demand and engaging and empowering other community providers. She received her Master of Science in Nursing (MSN) in 2011 from the Massachusetts General Hospital Institute of Health Professions and her Master of Science in Nursing Midwifery in 2017 from Frontier Nursing University. She also holds certification as a Certified Addiction Registered Nurse – Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board (ANCB).

Objectives

At the end of this training, participants will have the knowledge necessary to:

  • Describe the prevalence of illicitly manufactured fentanyl in the US drug supply.
  • Explain the major pharmacologic properties of both fentanyl and buprenorphine.
  • Recall at least two “tools” that can help guide the process of starting buprenorphine treatment.
  • Identify at least three medications that have been proven to support management of withdrawal symptoms during the buprenorphine initiation process.

For more information and to register click here

Event Details

Date:
June 5, 2024
Time:
2:00 pm - 3:00 pm
Location:
virtual
Cost:
free